ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
Dow Jones
38.589,16
-0,15%
Euro vs US Dollar
1,07175
0,00%
Bitcoin
66.572,50
0,57%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Transgene S.A. ADS (MM) (TRGNY)

  7. Transgene S.A. ADS (MM) (TRGNY) News

TRGNY

Transgene . (TRGNY)

Transgene S.A. ADS (MM)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:TRGNY
DatumZeitQuelleÜberschriftSymbolFirma
19/10/200508h00PR Newswire (US)Transgene : Cash Position and Net Cash Expenditures as of September 30, 2005NASDAQ:TRGNY
21/09/200507h01PR Newswire (US)Transgene to Voluntarily Delist From NasdaqNASDAQ:TRGNY
03/08/200507h01PR Newswire (US)Transgene Announces First Half 2005 Financial ResultsNASDAQ:TRGNY
21/07/200507h01PR Newswire (US)Transgene Announces Achievement of Clinical Milestone by Merck & Co., Inc. Using Transgene's Proprietary TechnologyNASDAQ:TRGNY
11/07/200519h01PR Newswire (US)Transgene Raises Euro 34.9 MillionNASDAQ:TRGNY
20/05/200507h01PR Newswire (US)Transgene Announces 20-F Form FilingNASDAQ:TRGNY
17/05/200507h01PR Newswire (US)Transgene's Therapeutic Vaccine MVA-MUC1-IL2 at ASCO:NASDAQ:TRGNY
16/05/200507h01PR Newswire (US)Transgene Presents Updated Positive Phase II Data of Its Therapeutic Vaccine MVA-MUC1-IL2 In Prostate Cancer at Annual ASCO MeetNASDAQ:TRGNY
26/04/200507h01PR Newswire (US)Transgene to Present at the 2nd Rodman & Renshaw Annual Global Healthcare ConferenceNASDAQ:TRGNY
13/04/200507h01PR Newswire (US)Transgene: Cash Position and Net Cash Expenditures as of March 31, 2005NASDAQ:TRGNY
05/04/200507h01PR Newswire (US)Transgene to Present Phase II Data of Its MVA-UC1-IL2 Cancer Vaccine at ASCO's 2005 Annual MeetingNASDAQ:TRGNY
23/02/200507h00PR Newswire (US)Transgene Announces Fiscal Year 2004 Financial ResultsNASDAQ:TRGNY
23/02/200507h00PR Newswire (US)Transgene: New Strategy in Therapeutic Vaccines, MVA-Muc1-IL2 Meets Primary Endpoint in Lung Cancer Phase IINASDAQ:TRGNY
15/02/200506h01PR Newswire (US)Transgene Appoints Jean-Yves Bonnefoy as New Chief Scientific OfficerNASDAQ:TRGNY
08/12/200406h01PR Newswire (US)Transgene Appoints Philippe Archinard As New Chief Executive OfficerNASDAQ:TRGNY
30/11/200417h34PR Newswire (US)Transgene Moves Forward Its Vaccine Candidate MVA-HPV-IL2 In A Novel Approach Against Pre-Cancerous Cervical LesionsNASDAQ:TRGNY
03/11/200406h01PR Newswire (US)Transgene: Cash Position and Net Cash Expenditures as of September 30, 2004NASDAQ:TRGNY
04/08/200407h01PR Newswire (US)Transgene Announces Second Quarter and First Half 2004 Financial ResultsNASDAQ:TRGNY
01/07/200415h31PR Newswire (US)Transgene Manufactures Clinical Lots of HIV Vaccine Candidates for the EUROVAC ProjectNASDAQ:TRGNY
15/06/200408h00PR Newswire (US)Merial and Transgene Sign a Collaboration Agreement to Develop Products for Animal HealthNASDAQ:TRGNYTransgene S.A. ADS (MM)
15/06/200407h01PR Newswire (US)Merial and Transgene Sign a Collaboration Agreement to Develop Products for Animal HealthNASDAQ:TRGNY
08/06/200407h01PR Newswire (US)Transgene Presents Data on MVA-MUC1-IL2 Cancer Vaccine at ASCO and ASGT Annual MeetingsNASDAQ:TRGNY
12/05/200415h45PR Newswire (US)Transgene to Present Data at 2004 ASCO Annual MeetingNASDAQ:TRGNY
05/05/200407h01PR Newswire (US)Transgene Announces First Quarter 2004 Financial ResultsNASDAQ:TRGNY
14/04/200407h01PR Newswire (US)Transgene: Data Presented at The American Association of Cancer Research Annual Meeting Suggest Significant Opportunities for AnNASDAQ:TRGNY
18/03/200406h01PR Newswire (US)Transgene's MVA-HPV-IL2 Vaccine Shows Activity in Phase II Clinical TrialNASDAQ:TRGNY
11/02/200406h01PR Newswire (US)Transgene Announces Fourth Quarter and Fiscal Year 2003 Financial ResultsNASDAQ:TRGNY
09/02/200406h00PR Newswire (US)Transgene Reports Positive Interim Phase II Data from MVA-Muc1-IL2 Cancer Vaccine ProgramNASDAQ:TRGNY
05/11/200306h01PR Newswire (US)Transgene Announces Third Quarter 2003 Financial ResultsNASDAQ:TRGNY
03/11/200306h01PR Newswire (US)Transgene Signs Pre-Clinical AIDS Vaccine Manufacturing Agreement With ANRS and INSERMNASDAQ:TRGNY
 Showing the most relevant articles for your search:NASDAQ:TRGNY

Kürzlich von Ihnen besucht

CCOM
US30
US 30
TG
D7G
Nel ASA
NYSE
XOM
Exxon Mobil
USOTC
RHHBY
Roche (QX)
NASDAQ
TSLA
Tesla
TG
RHM
Rheinmetall
AMEX
XLV
Health Care Select Sector
NYSE
NKE
Nike
CCOM
US100
US Tech 100
NASDAQ
AAPL
Apple
AMEX
XLE
Energy Select Sector SPDR
PM
XAUUSD
Gold vs US Dollar
TG
TUI1
Tui
NASDAQ
GOOGL
Alphabet
NASDAQ
MSFT
Microsoft
NASDAQ
NVDA
NVIDIA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten